Surprisingly, IL-1β blockade increased the number of neutrophils, the second major constituent of immune clusters, that is in contrast to previous observations, where mice with NASH treated with NLRP3 inhibitors showed decreased hepatic neutrophil infiltration51. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.